Insider Stock Trading History of Mulligan Seamus


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mulligan Seamus since year 2005. The trader's CIK number is 1536639. At the time of this reporting, Mulligan Seamus is the Director of Jazz Pharmaceuticals Inc . (stock ticker symbol JAZZ). See this page for all insider trading activities at Jazz Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Mulligan Seamus since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-08-25 JAZZ Jazz Pharmaceuticals Inc Sale 27,968 128.19 3,585,078
2016-05-24 JAZZ Jazz Pharmaceuticals Inc Sale 27,968 150.13 4,198,807
2016-02-23 JAZZ Jazz Pharmaceuticals Inc Sale 27,968 122.83 3,435,197
2015-11-20 JAZZ Jazz Pharmaceuticals Inc Sale 17,725 145.70 2,582,567
2015-11-23 JAZZ Jazz Pharmaceuticals Inc Sale 10,243 147.65 1,512,419
2015-03-25 JAZZ Jazz Pharmaceuticals Inc Sale 50,000 176.22 8,810,750
2015-03-18 JAZZ Jazz Pharmaceuticals Inc Sale 50,000 185.00 9,250,000
2014-12-23 JAZZ Jazz Pharmaceuticals Inc Sale 33,275 163.26 5,432,543
2014-12-24 JAZZ Jazz Pharmaceuticals Inc Sale 13,417 164.98 2,213,590
2014-12-26 JAZZ Jazz Pharmaceuticals Inc Sale 3,308 166.34 550,249
2014-09-25 JAZZ Jazz Pharmaceuticals Inc Sale 14,706 162.60 2,391,195
2014-09-24 JAZZ Jazz Pharmaceuticals Inc Sale 35,294 163.33 5,764,569
2014-09-11 JAZZ Jazz Pharmaceuticals Inc Sale 50,000 175.00 8,750,000
2014-06-24 JAZZ Jazz Pharmaceuticals Inc Sale 49,953 150.70 7,528,116
2014-06-25 JAZZ Jazz Pharmaceuticals Inc Sale 47 148.64 6,986
2014-03-04 JAZZ Jazz Pharmaceuticals Inc Sale 550,000 156.25 85,937,500
2013-03-08 JAZZ Jazz Pharmaceuticals Inc Sale 425,000 58.28 24,769,000
2012-03-09 JAZZ Jazz Pharmaceuticals Inc Sale 2,000,000 49.56 99,120,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mulligan Seamus (Director of Jazz Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.